HEADER TRANSFERASE 28-JUN-20 6ZJF TITLE CRYSTAL STRUCTURE OF STK17B (DRAK2) IN COMPLEX WITH AP-229 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 17B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DAP KINASE-RELATED APOPTOSIS-INDUCING PROTEIN KINASE 2; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK17B, DRAK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: -R3-PRARE2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS KINASE INHIBITOR, DRAK2, STK17B, STRUCTURAL GENOMICS, STRUCTURAL KEYWDS 2 GENOMICS CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.CHAIKUAD,A.PICADO,T.WILLSON,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (SGC) REVDAT 3 31-JAN-24 6ZJF 1 REMARK REVDAT 2 13-JAN-21 6ZJF 1 JRNL REVDAT 1 29-JUL-20 6ZJF 0 JRNL AUTH A.PICADO,A.CHAIKUAD,C.I.WELLS,S.SHRESTHA,W.J.ZUERCHER, JRNL AUTH 2 J.E.PICKETT,F.E.KWARCINSKI,P.SINHA,C.S.DE SILVA,R.ZUTSHI, JRNL AUTH 3 S.LIU,N.KANNAN,S.KNAPP,D.H.DREWRY,T.M.WILLSON JRNL TITL A CHEMICAL PROBE FOR DARK KINASE STK17B DERIVES ITS POTENCY JRNL TITL 2 AND HIGH SELECTIVITY THROUGH A UNIQUE P-LOOP CONFORMATION. JRNL REF J.MED.CHEM. V. 63 14626 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 33215924 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01174 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 39226 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2036 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2853 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2880 REMARK 3 BIN FREE R VALUE SET COUNT : 130 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2358 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37000 REMARK 3 B22 (A**2) : -0.37000 REMARK 3 B33 (A**2) : 0.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.100 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.099 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.073 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.680 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2577 ; 0.014 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2372 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3503 ; 1.496 ; 1.639 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5536 ; 1.381 ; 1.572 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 323 ; 6.570 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 137 ;33.859 ;23.504 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 461 ;13.600 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;22.326 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 340 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2963 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 524 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 17 A 309 REMARK 3 ORIGIN FOR THE GROUP (A): 60.1676 11.9419 -5.3187 REMARK 3 T TENSOR REMARK 3 T11: 0.0100 T22: 0.0427 REMARK 3 T33: 0.0155 T12: -0.0035 REMARK 3 T13: -0.0009 T23: 0.0144 REMARK 3 L TENSOR REMARK 3 L11: 0.0865 L22: 0.4190 REMARK 3 L33: 0.2596 L12: 0.1722 REMARK 3 L13: -0.1341 L23: -0.2642 REMARK 3 S TENSOR REMARK 3 S11: 0.0079 S12: -0.0034 S13: 0.0101 REMARK 3 S21: 0.0004 S22: 0.0100 S23: 0.0055 REMARK 3 S31: 0.0041 S32: 0.0264 S33: -0.0179 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 6ZJF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1292109655. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P13 (MX1) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03320 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41311 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 37.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.86500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3LM0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 19% PEG 3350, 0.1M NACL, 0.1M BIS-TRIS REMARK 280 6.0, PH 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.12950 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.56475 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 85.69425 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.12950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 85.69425 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 28.56475 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 613 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 623 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 707 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 SER A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 VAL A 13 REMARK 465 ASP A 14 REMARK 465 LEU A 15 REMARK 465 GLY A 16 REMARK 465 SER A 310 REMARK 465 SER A 311 REMARK 465 GLN A 312 REMARK 465 THR A 313 REMARK 465 GLN A 314 REMARK 465 ASP A 315 REMARK 465 HIS A 316 REMARK 465 SER A 317 REMARK 465 VAL A 318 REMARK 465 ARG A 319 REMARK 465 SER A 320 REMARK 465 SER A 321 REMARK 465 GLU A 322 REMARK 465 ASP A 323 REMARK 465 LYS A 324 REMARK 465 THR A 325 REMARK 465 SER A 326 REMARK 465 LYS A 327 REMARK 465 SER A 328 REMARK 465 SER A 329 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 17 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 501 O HOH A 508 2.14 REMARK 500 ND2 ASN A 95 O HOH A 501 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 256 CD GLU A 256 OE1 0.070 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 158 38.94 -144.99 REMARK 500 ASP A 179 82.09 70.06 REMARK 500 GLU A 191 -157.18 -107.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QM2 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 403 DBREF 6ZJF A 25 329 UNP O94768 ST17B_HUMAN 25 329 SEQADV 6ZJF MET A 3 UNP O94768 INITIATING METHIONINE SEQADV 6ZJF HIS A 4 UNP O94768 EXPRESSION TAG SEQADV 6ZJF HIS A 5 UNP O94768 EXPRESSION TAG SEQADV 6ZJF HIS A 6 UNP O94768 EXPRESSION TAG SEQADV 6ZJF HIS A 7 UNP O94768 EXPRESSION TAG SEQADV 6ZJF HIS A 8 UNP O94768 EXPRESSION TAG SEQADV 6ZJF HIS A 9 UNP O94768 EXPRESSION TAG SEQADV 6ZJF SER A 10 UNP O94768 EXPRESSION TAG SEQADV 6ZJF SER A 11 UNP O94768 EXPRESSION TAG SEQADV 6ZJF GLY A 12 UNP O94768 EXPRESSION TAG SEQADV 6ZJF VAL A 13 UNP O94768 EXPRESSION TAG SEQADV 6ZJF ASP A 14 UNP O94768 EXPRESSION TAG SEQADV 6ZJF LEU A 15 UNP O94768 EXPRESSION TAG SEQADV 6ZJF GLY A 16 UNP O94768 EXPRESSION TAG SEQADV 6ZJF THR A 17 UNP O94768 EXPRESSION TAG SEQADV 6ZJF GLU A 18 UNP O94768 EXPRESSION TAG SEQADV 6ZJF ASN A 19 UNP O94768 EXPRESSION TAG SEQADV 6ZJF LEU A 20 UNP O94768 EXPRESSION TAG SEQADV 6ZJF TYR A 21 UNP O94768 EXPRESSION TAG SEQADV 6ZJF PHE A 22 UNP O94768 EXPRESSION TAG SEQADV 6ZJF GLN A 23 UNP O94768 EXPRESSION TAG SEQADV 6ZJF SER A 24 UNP O94768 EXPRESSION TAG SEQRES 1 A 327 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 327 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLU ASN PHE SEQRES 3 A 327 ASN ASN PHE TYR ILE LEU THR SER LYS GLU LEU GLY ARG SEQRES 4 A 327 GLY LYS PHE ALA VAL VAL ARG GLN CYS ILE SER LYS SER SEQRES 5 A 327 THR GLY GLN GLU TYR ALA ALA LYS PHE LEU LYS LYS ARG SEQRES 6 A 327 ARG ARG GLY GLN ASP CYS ARG ALA GLU ILE LEU HIS GLU SEQRES 7 A 327 ILE ALA VAL LEU GLU LEU ALA LYS SER CYS PRO ARG VAL SEQRES 8 A 327 ILE ASN LEU HIS GLU VAL TYR GLU ASN THR SER GLU ILE SEQRES 9 A 327 ILE LEU ILE LEU GLU TYR ALA ALA GLY GLY GLU ILE PHE SEQRES 10 A 327 SER LEU CYS LEU PRO GLU LEU ALA GLU MET VAL SER GLU SEQRES 11 A 327 ASN ASP VAL ILE ARG LEU ILE LYS GLN ILE LEU GLU GLY SEQRES 12 A 327 VAL TYR TYR LEU HIS GLN ASN ASN ILE VAL HIS LEU ASP SEQRES 13 A 327 LEU LYS PRO GLN ASN ILE LEU LEU SER SER ILE TYR PRO SEQRES 14 A 327 LEU GLY ASP ILE LYS ILE VAL ASP PHE GLY MET SER ARG SEQRES 15 A 327 LYS ILE GLY HIS ALA CYS GLU LEU ARG GLU ILE MET GLY SEQRES 16 A 327 THR PRO GLU TYR LEU ALA PRO GLU ILE LEU ASN TYR ASP SEQRES 17 A 327 PRO ILE THR THR ALA THR ASP MET TRP ASN ILE GLY ILE SEQRES 18 A 327 ILE ALA TYR MET LEU LEU THR HIS THR SER PRO PHE VAL SEQRES 19 A 327 GLY GLU ASP ASN GLN GLU THR TYR LEU ASN ILE SER GLN SEQRES 20 A 327 VAL ASN VAL ASP TYR SER GLU GLU THR PHE SER SER VAL SEQRES 21 A 327 SER GLN LEU ALA THR ASP PHE ILE GLN SER LEU LEU VAL SEQRES 22 A 327 LYS ASN PRO GLU LYS ARG PRO THR ALA GLU ILE CYS LEU SEQRES 23 A 327 SER HIS SER TRP LEU GLN GLN TRP ASP PHE GLU ASN LEU SEQRES 24 A 327 PHE HIS PRO GLU GLU THR SER SER SER SER GLN THR GLN SEQRES 25 A 327 ASP HIS SER VAL ARG SER SER GLU ASP LYS THR SER LYS SEQRES 26 A 327 SER SER HET QM2 A 401 23 HET EDO A 402 4 HET EDO A 403 8 HETNAM QM2 2-[6-(4-CYCLOPROPYLPHENYL)THIENO[3,2-D]PYRIMIDIN-4- HETNAM 2 QM2 YL]SULFANYLETHANOIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 QM2 C17 H14 N2 O2 S2 FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 HOH *231(H2 O) HELIX 1 AA1 MET A 25 PHE A 31 1 7 HELIX 2 AA2 CYS A 73 ALA A 87 1 15 HELIX 3 AA3 LYS A 88 CYS A 90 5 3 HELIX 4 AA4 PHE A 119 VAL A 130 5 12 HELIX 5 AA5 SER A 131 ASN A 152 1 22 HELIX 6 AA6 LYS A 160 GLN A 162 5 3 HELIX 7 AA7 ARG A 193 GLY A 197 5 5 HELIX 8 AA8 THR A 198 LEU A 202 5 5 HELIX 9 AA9 ALA A 203 ASN A 208 1 6 HELIX 10 AB1 THR A 213 HIS A 231 1 19 HELIX 11 AB2 ASP A 239 VAL A 250 1 12 HELIX 12 AB3 SER A 255 SER A 260 1 6 HELIX 13 AB4 SER A 263 LEU A 274 1 12 HELIX 14 AB5 ASN A 277 ARG A 281 5 5 HELIX 15 AB6 THR A 283 SER A 289 1 7 HELIX 16 AB7 HIS A 290 GLN A 294 5 5 SHEET 1 AA1 6 GLN A 23 SER A 24 0 SHEET 2 AA1 6 LEU A 96 GLU A 101 1 O GLU A 101 N GLN A 23 SHEET 3 AA1 6 GLU A 105 GLU A 111 -1 O ILE A 109 N GLU A 98 SHEET 4 AA1 6 GLU A 58 LYS A 65 -1 N ALA A 60 O LEU A 110 SHEET 5 AA1 6 ALA A 45 SER A 52 -1 N ARG A 48 O ALA A 61 SHEET 6 AA1 6 TYR A 32 ARG A 41 -1 N GLY A 40 O VAL A 47 SHEET 1 AA2 2 ARG A 67 ARG A 68 0 SHEET 2 AA2 2 GLN A 71 ASP A 72 -1 O GLN A 71 N ARG A 68 SHEET 1 AA3 3 GLY A 116 GLU A 117 0 SHEET 2 AA3 3 ILE A 164 LEU A 166 -1 O LEU A 166 N GLY A 116 SHEET 3 AA3 3 ILE A 175 ILE A 177 -1 O LYS A 176 N LEU A 165 CISPEP 1 TYR A 170 PRO A 171 0 -0.79 SITE 1 AC1 13 GLU A 38 LEU A 39 ARG A 41 ALA A 60 SITE 2 AC1 13 LYS A 62 GLU A 111 TYR A 112 ALA A 113 SITE 3 AC1 13 GLY A 116 LEU A 165 ASP A 179 EDO A 402 SITE 4 AC1 13 HOH A 505 SITE 1 AC2 5 GLU A 80 VAL A 178 ASP A 179 PHE A 180 SITE 2 AC2 5 QM2 A 401 SITE 1 AC3 6 TYR A 32 SER A 52 SER A 54 HIS A 97 SITE 2 AC3 6 GLU A 98 HOH A 700 CRYST1 83.349 83.349 114.259 90.00 90.00 90.00 P 41 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011998 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011998 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008752 0.00000